These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis. Bagan J, Peydró A, Calvo J, Leopoldo M, Jiménez Y, Bagan L. Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808 [Abstract] [Full Text] [Related]
6. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M. Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439 [Abstract] [Full Text] [Related]
7. Update MRONJ and perspectives of its treatment. Voss PJ, Poxleitner P, Schmelzeisen R, Stricker A, Semper-Hogg W. J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987 [Abstract] [Full Text] [Related]
9. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P. Urol Nurs; 2016 Sep; 36(3):111-6, 154. PubMed ID: 27501591 [Abstract] [Full Text] [Related]
11. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report. Diniz-Freitas M, Fernández-Feijoo J, Diz Dios P, Pousa X, Limeres J. J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739 [Abstract] [Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment? Favia G, Tempesta A, Limongelli L, Crincoli V, Maiorano E. Oral Dis; 2018 Mar; 24(1-2):238-242. PubMed ID: 29480596 [Abstract] [Full Text] [Related]
13. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. Ristow O, Rückschloß T, Müller M, Berger M, Kargus S, Pautke C, Engel M, Hoffmann J, Freudlsperger C. J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734 [Abstract] [Full Text] [Related]
14. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature. Chehal H, Nikitakis NG, Islam MN, Goodchild JH, Mordini L, Bhattacharyya I. Gen Dent; 2019 Mar; 67(1):42-46. PubMed ID: 30644830 [Abstract] [Full Text] [Related]
17. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M. PLoS One; 2018 Mar; 13(7):e0201343. PubMed ID: 30048523 [Abstract] [Full Text] [Related]
18. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ. Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135 [Abstract] [Full Text] [Related]
19. Denosumab: a case of MRONJ with resolution. Lyttle CV, Patterson H. Br Dent J; 2016 Jun 24; 220(12):623-5. PubMed ID: 27338901 [Abstract] [Full Text] [Related]